Clinical Trials Directory

Trials / Completed

CompletedNCT01484717

Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
90 (actual)
Sponsor
UConn Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cigarette smoking remains the most common source of preventable morbidity and mortality in the United States, with in excess of $167 billion in economic costs per year. Contingency management (CM), in which tangible incentives are provided contingent on a target behavior like abstinence, is highly efficacious in improving substance abuse treatment outcomes and is receiving increased attention for smoking cessation. Expired carbon monoxide (CO) is the most common objective smoking status test used in smoking research and treatment. Unfortunately, multiple CO tests/day are typically required to detect all smoking and reinforce sustained abstinence. The resulting logistical and resource limitations greatly limit the application of this potentially powerful quit smoking toolset. This study addresses these limitations by examining the effectiveness of using interactive voice response technology (IVR) to implement CM. Smokers who want to quit (N = 90 randomized) will receive 2 quit preparation sessions based on public health guidelines for smoking cessation and set a target quit date. Participants will be randomly assigned to 1 of 2 treatment conditions: (a) IVR-S consisting of objective smoking status monitoring using IVR, telephone counseling and transdermal nicotine and (b) IVR-CM, consisting of the same monitoring, telephone counseling and transdermal nicotine plus IVR-based CM for smoking abstinence. It is hypothesized that abstinence rates will be higher in the IVR-CM condition compared to the IVR-S, supporting a combined IVR CM approach, and thereby greatly increasing the applicability of these powerful smoking cessation tools.

Conditions

Interventions

TypeNameDescription
BEHAVIORALcontingency management for smoking abstinenceParticipants earn the chance to win prizes for breath samples that test negative for cigarette smoking.
DRUGtransdermal nicotineParticipants receive an 8 week supply of transdermal nicotine \[21 mg patches (4 wks), 14 mg (2 wks), 7 mg (2 wks)\].
BEHAVIORALTelephone counselingParticipants receive brief twice weekly telephone counseling.

Timeline

Start date
2012-01-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2011-12-02
Last updated
2017-02-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01484717. Inclusion in this directory is not an endorsement.